**Core Concept**
Methicillin-resistant Staphylococcus aureus (MRSA) refers to a type of Staphylococcus aureus bacteria that has developed resistance to beta-lactam antibiotics, including methicillin. This resistance is primarily due to the presence of the mecA gene, which encodes for an altered penicillin-binding protein (PBP2a).

**Why the Correct Answer is Right**
MRSA is not expected to respond to beta-lactam antibiotics, such as methicillin, oxacillin, and penicillin, due to the altered PBP2a. This enzyme has a low affinity for beta-lactam antibiotics, allowing MRSA to continue producing peptidoglycan and maintain its cell wall integrity even in the presence of these antibiotics. The mecA gene is responsible for encoding this altered PBP2a, making MRSA resistant to beta-lactam antibiotics.

**Why Each Wrong Option is Incorrect**
* **Option A:** Vancomycin is a glycopeptide antibiotic that inhibits cell wall synthesis by binding to the D-alanyl-D-alanine terminus of peptidoglycan precursors. It is effective against MRSA and is often used as a first-line treatment.
* **Option B:** Clindamycin is a lincosamide antibiotic that inhibits protein synthesis by binding to the 50S ribosomal subunit. It is effective against MRSA and is often used in combination with other antibiotics to treat infections.
* **Option C:** Trimethoprim-sulfamethoxazole is a combination antibiotic that inhibits folate synthesis by binding to dihydrofolate reductase. It is effective against MRSA and is often used to treat skin and soft tissue infections.

**Clinical Pearl / High-Yield Fact**
MRSA infections often present with signs of localized inflammation, such as redness, swelling, and warmth, and may require treatment with antibiotics that are effective against MRSA, such as vancomycin or clindamycin.

**Correct Answer:** D.